Jill Marie Broadfoot
CIK 1305178 · Chief Financial Officer · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LIFE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
10240 SORRENTO VALLEY ROAD, SUITE 300
SAN DIEGO, CA 92121
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TLPH | Director | 13,647 | $1.10 | $15.0K | $0 | 3 | 2026-06-24 |
| ATYR | Chief Financial Officer | 38,854 | $0.11 | $4.4K | -$1.5K | 1 | 2026-02-04 |
| LIFE | Chief Financial Officer | 35,104 | $42.62 | $1.50M | $86.0K | 21 | 2026-01-09 |
| CUE | Director | — | $18.16 | — | $0 | 2 | 2026-01-06 |
| TALPHERA, INC. (ACRX) Delisted | Director | 2,106 | $0.86 | $1.8K | $0 | 3 | 2023-12-13 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 2 | 2022-06-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sr Vice President, CFO, Sec | 2,081 | — | — | $961 | 10 | 2013-04-03 |
Recent Filings · Page 4 of 5
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-18 | LIFE | Buy (P) | +26,000 | $19.1K | EDGAR |
| 2018-08-01 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2013-04-03 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Tax (F) | −38,121 | -$147.9K | EDGAR |
| 2013-01-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +24,690 | -$7.6K | EDGAR |
| 2012-01-18 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +27,000 | $270 | EDGAR |
| 2011-01-11 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +60,000 | $600 | EDGAR |
| 2010-01-26 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Buy (P) | +50,000 | $500 | EDGAR |
| 2010-01-12 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | −50,000 | -$500 | EDGAR |
| 2009-01-12 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | −35,000 | -$350 | EDGAR |
| 2008-01-07 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +7,000 | $70 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.